Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Clear all

423 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
20024
20033
20044
20052
20066
200710
20089
200925
201011
20116
201214
20139
201419
201513
201613
201723
201821
201931
202023
202135
202224
202319
202423
202530
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174
Unknown status70
Recruiting65
Terminated48
Active, not recruiting28
Not yet recruiting19
Withdrawn14
Suspended4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
M.D. Anderson Cancer Center8
AbbVie7
Incyte Corporation6
West China Hospital6
Beijing 302 Hospital5
Beijing Ditan Hospital5
City of Hope Medical Center5
Fudan University5
Pfizer5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular423
Liver Neoplasms79
Carcinoma, Non-Small-Cell Lung63
Stomach Neoplasms61
Carcinoma, Renal Cell56
Neoplasms54
Melanoma50
Pancreatic Neoplasms45
Colorectal Neoplasms43
Breast Neoplasms41

Trials

Showing 26 to 50 of 423. Each trial links to its page on Pharma Observatory.

323 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.